Scinai Immunotherapeutics (SCNI) Receivables - Other (2020 - 2026)
Scinai Immunotherapeutics (SCNI) posted Receivables - Other of $350.0 million for Q1 2026, up 105.88% sequentially from $170.0 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Receivables - Other (2020 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Receivables - Other for 7 years, with the latest figure at $350.0 million in Q1 2026.
- Quarterly Receivables - Other changed N/A year-over-year to $350.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350.0 million (changed N/A YoY) and the FY2025 annual result came in at $170.0 million, up 79712.21% from the prior year.
- Receivables - Other climbed to $350.0 million in Q1 2026 per SCNI's latest filing, from $170.0 million in the prior quarter.
- Over five years, Receivables - Other peaked at $350.0 million in Q1 2026 and troughed at -$123000.0 in Q1 2022.
- A 5-year average of $34.8 million and a median of $228000.0 in 2023 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2025: Receivables - Other plunged 52.45% in 2022, then jumped 79712.21% in 2025.
- Over 5 years, Receivables - Other stood at $155000.0 in 2022, then jumped by 181.94% to $437000.0 in 2023, then tumbled by 51.26% to $213000.0 in 2024, then surged by 79712.21% to $170.0 million in 2025, then jumped by 105.88% to $350.0 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $350.0 million, $170.0 million, and $236000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 350.00 Mn |
| Mar 31, 2026 | 350.00 Mn |
| Dec 31, 2025 | 170.00 Mn |
| Dec 31, 2025 | 170.00 Mn |
| Jun 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 236,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 328,000.00 |
| Sep 30, 2024 | 328,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 288,000.00 |
| Mar 31, 2024 | 288,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 138,000.00 |
| Jun 30, 2023 | 138,000.00 |